Structure |
Chemical Name |
CAS |
MF |
![Ipragliflozin Impurity 3](/) |
Ipragliflozin Impurity 3 |
|
|
![Isavuconazole Impurity 30](/) |
Isavuconazole Impurity 30 |
|
|
![Levetiracetam Impurity 27](/) |
Levetiracetam Impurity 27 |
|
|
![Linagliptin Impurity 58](/) |
Linagliptin Impurity 58 |
|
|
![Oseltamivir Impurity 33](/) |
Oseltamivir Impurity 33 |
|
|
![Oseltamivir Impurity 49](/) |
Oseltamivir Impurity 49 |
|
|
![Palbociclib Impurity 52](/) |
Palbociclib Impurity 52 |
|
|
![Palbociclib Impurity 37](/) |
Palbociclib Impurity 37 |
|
|
![Pazufloxacin Impurity 16](/CAS/20210305/GIF/165071-10-3.gif) |
Pazufloxacin Impurity 16 |
165071-10-3 |
C14H10FNO6 |
![Pimecrolimus Impurity 4](/) |
Pimecrolimus Impurity 4 |
|
|
![Posaconazole Impurity 73](/) |
Posaconazole Impurity 73 |
|
|
![Rosuvastatin Impurity 90](/CAS/20210111/GIF/2226413-62-1.gif) |
Rosuvastatin Impurity 90 |
2226413-62-1 |
C38H44F2N6O8S2 |
![Tofacitinib Impurity 110](/) |
Tofacitinib Impurity 110 |
|
|
![Tofacitinib Impurity 115](/) |
Tofacitinib Impurity 115 |
|
|
![Trelagliptin Impurity 27](/) |
Trelagliptin Impurity 27 |
|
|
![Vildagliptin Impurity 30](/CAS/20200611/GIF/918830-94-1.gif) |
Vildagliptin Impurity 30 |
918830-94-1 |
C10H17NO2 |
![N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine](/CAS/20200401/GIF/CB84908513.gif) |
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine |
|
C13H19N5 |
![Tolvaptan Impurity 6](/CAS/20200611/GIF/1432725-24-0.gif) |
Tolvaptan Impurity 6 |
1432725-24-0 |
C18H19ClN2O2 |
![Esmolol impurity B](/) |
Esmolol impurity B |
|
|
![Esmolol impurity F](/) |
Esmolol impurity F |
|
|
![Diquafosol Impurity E](/) |
Diquafosol Impurity E |
|
|
![Bortezomib Impurity 39](/) |
Bortezomib Impurity 39 |
|
|
![Sunitinib Impurity 5](/) |
Sunitinib Impurity 5 |
|
|
![Silodosin Impurity 6](/) |
Silodosin Impurity 6 |
|
|
![Erlotinib Impurity 19](/) |
Erlotinib Impurity 19 |
|
|
![Ticagrelor Impurity 40](/) |
Ticagrelor Impurity 40 |
|
|
![Moxifloxacin Impurity 12](/) |
Moxifloxacin Impurity 12 |
|
|
![Cabozantinib Impurity 4](/) |
Cabozantinib Impurity 4 |
|
|
![Lenvatinib Impurity 35](/) |
Lenvatinib Impurity 35 |
|
|
![Febuxostat Impurity 58](/) |
Febuxostat Impurity 58 |
|
|
![Cefodizime Impurity B](/) |
Cefodizime Impurity B |
|
|
![Cefodizime Impurity D](/) |
Cefodizime Impurity D |
|
|
![Penicillin Impurity B](/) |
Penicillin Impurity B |
|
|
![4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid]](/CAS/20200401/GIF/1644566-39-1.gif) |
4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzoic acid] |
1644566-39-1 |
C17H13N3O4 |
![Cefminox Sodium impurity B](/) |
Cefminox Sodium impurity B |
|
|
![Cefotiam Impurity B](/) |
Cefotiam Impurity B |
|
|
![pranoprofen impurity 11](/CAS/20210111/GIF/52549-44-7.gif) |
pranoprofen impurity 11 |
52549-44-7 |
C15H13NO4 |
![Cefazolin Impurity 5](/) |
Cefazolin Impurity 5 |
|
|
![Peramivir Impurity E](/) |
Peramivir Impurity E |
|
|
![Lincomycin sulfoxide Impurity 3](/) |
Lincomycin sulfoxide Impurity 3 |
|
|
![Lincomycin sulfoxide Impurity F](/) |
Lincomycin sulfoxide Impurity F |
|
|
![Fasudil iMpurity F](/) |
Fasudil iMpurity F |
|
|
![1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride](/CAS/20200401/GIF/2252446-70-9.gif) |
1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-70-9 |
C22H27ClFN3O4 |
![Doxofylline iMpurity E](/) |
Doxofylline iMpurity E |
|
|
![Mupirocin Impurity 3](/CAS/20200401/GIF/CB84943000.gif) |
Mupirocin Impurity 3 |
|
C26H44O9 |
![3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE](/CAS/GIF/49552-34-3.gif) |
3,4-DICHLOROBENZYLAMINE HYDROCHLORIDE |
49552-34-3 |
C7H8Cl3N |
![(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine](/CAS/GIF/147769-93-5.gif) |
(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine |
147769-93-5 |
C16H26N2 |
![4,4′-DIPHENOQUINONE (DQ)](/CAS/GIF/494-72-4.gif) |
4,4′-DIPHENOQUINONE (DQ) |
494-72-4 |
C12H8O2 |
![S-(+)-O-DESMETHYL VENLAFAXINE](/CAS/GIF/142761-12-4.gif) |
S-(+)-O-DESMETHYL VENLAFAXINE |
142761-12-4 |
C16H25NO2 |
![ACETYLSIMVASTATIN](/CAS/GIF/145576-25-6.gif) |
ACETYLSIMVASTATIN |
145576-25-6 |
C27H40O6 |
![5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE](/CAS/GIF/120568-11-8.gif) |
5-[2-(4'-METHYLBIPHENYL)]TETRAZOLE |
120568-11-8 |
C14H12N4 |
![L-2-Aminobutanamide](/CAS/GIF/7324-11-0.gif) |
L-2-Aminobutanamide |
7324-11-0 |
C4H10N2O |
![Dihydro-Simvastatin](/CAS/20200401/GIF/92083-03-9.gif) |
Dihydro-Simvastatin |
92083-03-9 |
C25H40O5 |
![Ceftriaxone Sodium impurity 3](/) |
Ceftriaxone Sodium impurity 3 |
|
|
![Sugammadex sodium Monoiodo Impurity](/) |
Sugammadex sodium Monoiodo Impurity |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
![176760-99-9](/CAS/20200611/GIF/176760-99-9.gif) |
176760-99-9 |
176760-99-9 |
C17H13FN2O4 |
![NILOTINIB IMPURITY 17](/CAS/20210111/GIF/851137-91-2.gif) |
NILOTINIB IMPURITY 17 |
851137-91-2 |
C17H15N5O |
![DexMedetoMidine IMpurity 16](/) |
DexMedetoMidine IMpurity 16 |
|
|
![Canagliflozin Impurity 2](/) |
Canagliflozin Impurity 2 |
|
|
![Rivaroxaban Impurity 22](/) |
Rivaroxaban Impurity 22 |
|
|
![Levofloxacin Impurity 5](/CAS/20200401/GIF/2206360-62-3.gif) |
Levofloxacin Impurity 5 |
2206360-62-3 |
C13H10FNO5 |
![Ezetimibe Impurity 33](/) |
Ezetimibe Impurity 33 |
|
|
![Ezetimibe-28](/CAS/20210111/GIF/1478663-95-4.gif) |
Ezetimibe-28 |
1478663-95-4 |
C44H52F2N2O6Si |
![Vonoprazan Impurity U4](/) |
Vonoprazan Impurity U4 |
|
|
![Emtricitabine Impurity 28](/CAS/20200515/GIF/1238210-14-4.gif) |
Emtricitabine Impurity 28 |
1238210-14-4 |
C8H11N3O4S |
![Parecoxib SodiuM iMpurity 37](/) |
Parecoxib SodiuM iMpurity 37 |
|
|
![(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound](/CAS/20200611/GIF/105834-21-7.gif) |
(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound |
105834-21-7 |
C20H22FNO3 |
![Cabozantinib Impurity 46](/CAS/20200515/GIF/1247859-37-5.gif) |
Cabozantinib Impurity 46 |
1247859-37-5 |
C11H10FNO3 |
![Ivabradine Impurity S33172](/CAS/20200515/GIF/2247881-26-9.gif) |
Ivabradine Impurity S33172 |
2247881-26-9 |
C26H34N2O5 |
![Tenofovir Impurity 71](/) |
Tenofovir Impurity 71 |
|
|
![2-(chloromethyl)-3-methylpyridin-4-ol](/CAS/20200401/GIF/1805648-51-4.gif) |
2-(chloromethyl)-3-methylpyridin-4-ol |
1805648-51-4 |
C7H8ClNO |
![Mupirocin Calcium EP Impurity I](/CAS/20200401/GIF/CB85479591.gif) |
Mupirocin Calcium EP Impurity I |
|
C26H44CaO9 |
![Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod](/CAS/20210111/GIF/2243233-98-7.gif) |
Benzenepropanoic acid, α-hydroxy-β-[[(3E)-1-oxo-3-hexen-1-yl]amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclod |
2243233-98-7 |
C46H55NO14 |
![D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester](/CAS/20200611/GIF/1326303-05-2.gif) |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-6-S-(5-methyl-1,3,4-thiadiazol-2-yl)-6-thio-, 1,1-dimethylethyl ester |
1326303-05-2 |
C16H26N2O4S2 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
![5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy-](/CAS/20200401/GIF/2102609-59-4.gif) |
5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1,3-dihydro-1-hydroxy- |
2102609-59-4 |
C14H18N2O2 |
![L-Milnacipran Carbamoyl-beta-D-Glucuronide](/CAS/20211123/GIF/1446438-98-7.gif) |
L-Milnacipran Carbamoyl-beta-D-Glucuronide |
1446438-98-7 |
C22H30N2O9 |
![1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester](/CAS/20200401/GIF/2097255-05-3.gif) |
1H-Imidazole-1-carboxylic acid, (1R)-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-1-[[[(2R)-3-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-2-[(1H-imidazol-1-ylcarbonyl)oxy]propyl][4-(3-oxo-4-morpholinyl)phenyl]amino]methyl]ethyl ester |
2097255-05-3 |
C40H34N8O10 |
![Elagolix Sodium impurity5](/) |
Elagolix Sodium impurity5 |
|
|
![Tadalafil Impurity 46](/) |
Tadalafil Impurity 46 |
|
|
![(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol](/CAS/20200401/GIF/CB85519895.gif) |
(trans)-4-((2-amino-3,4-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
![cefdinir](/) |
cefdinir |
|
|
![1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl-](/CAS/20200401/GIF/91639-43-9.gif) |
1H-Inden-1-amine, 2,3-dihydro-N-2-propen-1-yl- |
91639-43-9 |
C12H15N |
![(E)-8-(3,4-dimethoxystyryl)](/) |
(E)-8-(3,4-dimethoxystyryl) |
|
|
![(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol](/) |
(trans)-3-(4-((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl)butane-1,2,4-triol |
|
|
![Cefdinir CP Impurity B](/) |
Cefdinir CP Impurity B |
|
|
![Voriconazole Impurity 15](/CAS/20210111/GIF/321589-00-8.gif) |
Voriconazole Impurity 15 |
321589-00-8 |
C22H19F4N7O |
![Fluconazole Impurity 2](/) |
Fluconazole Impurity 2 |
|
|
![Imatinib EP Impurity D Chloride](/) |
Imatinib EP Impurity D Chloride |
|
|
![Favipiravir Impurity](/) |
Favipiravir Impurity |
|
|
![Vildagliptin Dione Impurity](/CAS/20210111/GIF/1844894-70-7.gif) |
Vildagliptin Dione Impurity |
1844894-70-7 |
C17H24N2O3 |
![NA](/) |
NA |
|
|
![Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate](/CAS/20210111/GIF/1440961-11-4.gif) |
Citalopram impurity 9/Citalopram EP Impurity C Oxalate Salt/3-Oxo Citalopram Oxalate Salt/Citalopram Related Compound C Oxalate Salt/3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate |
1440961-11-4 |
C22H21FN2O6 |
![1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl-](/CAS/20210111/GIF/2170562-55-5.gif) |
1H-Pyrrole-3-carboxamide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-(2-hydroxyethyl)-2,4-dimethyl- |
2170562-55-5 |
C18H18FN3O3 |
![Favipiravir Impurity 14](/CAS/20210111/GIF/356783-49-8.gif) |
Favipiravir Impurity 14 |
356783-49-8 |
C5HClFN3 |
![Posaconazole Impurity 93](/CAS/20200611/GIF/165115-82-2.gif) |
Posaconazole Impurity 93 |
165115-82-2 |
C19H19F2IO2 |
![4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one](/) |
4-((3-amino-1H-indazol-5-yl)methyl)phthalazin-1(2H)-one |
|
|
![FUROSEMIDE IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB8587736.gif) |
FUROSEMIDE IMPURITY A |
|
C12H11ClN2O5S |
![GLICLAZIDE IMPURITY F](/) |
GLICLAZIDE IMPURITY F |
|
|